Krystal Biotech, Inc. (KRYS) /
The revenue of Krystal Biotech, Inc. over the past 10 years
Chart Krystal Biotech, Inc.: revenue, fiscal 2016–2025 Open the chart →Krystal Biotech, Inc. reported revenue of $389.13M in fiscal 2025, the latest fiscal year on file. In fiscal 2021 it was $0. Year over year, revenue rose 3 times. The largest one-year move was in fiscal 2024: up 473%, from $50.7M to $290.51M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $389.13M |
| 2024ended Dec 31, 2024 | $290.51M |
| 2023ended Dec 31, 2023 | $50.7M |
| 2022ended Dec 31, 2022 | $0 |
| 2021ended Dec 31, 2021 | $0 |
| 2020ended Dec 31, 2020 | — |
| 2019ended Dec 31, 2019 | — |
| 2018ended Dec 31, 2018 | — |
| 2017ended Dec 31, 2017 | — |
| 2016ended Dec 31, 2016 | — |
Fiscal years as Krystal Biotech, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Krystal Biotech, Inc.
- The profitability of Krystal Biotech, Inc.
- The cash flow of Krystal Biotech, Inc.
- The debt of Krystal Biotech, Inc.
- All of Krystal Biotech, Inc.'s financials, charted
Companies of a similar size
- ORIOLD REPUBLIC INTERNATIONAL CORPORATION
- LTHLife Time Group Holdings, Inc.
- TTEKTETRA TECH INC
- AURAurora Innovation, Inc.
- ATHMAutohome Inc.
Not investment advice. This page shows what Krystal Biotech, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.